Cytokinetics CYTK Cash Flow Statement (2010-2026)

NASDAQ CYTK
$63.95 +1.30 (+2.08%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Cytokinetics Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Cytokinetics reported cash from operations of -$159.80M and free cash flow of -$164.13M for the quarter ended Jun 2026, down 24.6% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-76.09M-30.57M-89.45M-19.82M-142.31M-137.38M-131.29M-128.64M-129.42M-136.90M-135.64M-143.32M-160.55M-150.02M-161.38M-134.37M-306.18M-183.03M-206.03M-198.76M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.46M0.73M1.34M1.41M1.41M1.66M1.85M1.86M1.85M6.34M2.33M2.41M2.41M2.38M2.30M2.29M2.68M2.86M3.38M3.63M
Share-based CompensationStock Comp.
7.77M6.71M9.00M12.20M13.20M13.45M15.20M18.67M18.72M19.49M21.61M24.62M25.36M26.25M23.55M27.54M30.70M30.51M30.39M35.71M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
-0.03M-0.60M0.70M1.20M-0.40M3.00M0.70M0.90M1.50M-1.10M
Cash from Restructuring
Other non-cash itemsOther Non-Cash
3.71M10.53M5.22M22.86M-2.05M4.79M-17.77M-2.35M-0.20M15.20M1.59M-5.39M14.60M124.05M-6.30M9.77M-2.40M
Change in Working Capital
Change in ReceivablesChange Receivables
-2.06M51.18M-50.76M-4.08M0.32M-2.15M0.86M-0.02M1.51M-1.22M-0.45M-0.83M0.24M16.41M-14.64M6.40M-6.60M15.96M-10.94M17.61M
Change in InventoryChange Inventory
3.57M2.26M
Change in Account PayablesChange Payables
-0.42M3.86M-3.08M-8.85M3.41M13.05M-8.11M-4.32M1.24M7.71M-10.29M-1.81M1.72M5.91M-4.58M0.95M6.60M-0.31M1.52M0.03M
Change in Accured ExpensesChange Accured Exp.
10.79M1.24M-3.52M6.08M8.64M-0.35M-7.76M-11.43M4.16M32.13M-5.58M4.17M5.51M10.08M-14.37M13.99M7.62M26.37M-6.21M5.25M
Change in Other Operating AssetsOther Assets Change
5.66M-3.86M1.42M6.61M0.91M-1.53M1.63M5.65M-0.34M-8.53M6.63M-8.16M-4.48M8.44M0.38M4.64M-6.28M4.20M-2.06M4.84M
Change in Other Operating LiabilitiesOther Liabilities Change
13.81M8.18M-2.25M-88.47M0.92M0.47M-0.83M-2.72M-2.74M-4.71M-3.65M-1.59M-1.58M50.58M-0.52M-55.01M-4.56M-7.75M-4.95M-5.81M
Other Working Capital ChangesOther WC Changes
8.15M12.04M-3.67M-95.08M0.01M2.00M-2.45M-8.37M-2.40M3.82M-10.28M6.57M2.90M42.14M-0.90M-59.65M1.71M-11.95M-2.90M-10.66M
Cash from OperationsCash from Ops.
-38.77M-44.74M-26.81M-90.48M-84.04M-98.19M-122.29M-121.81M-96.21M-74.04M-129.51M-99.31M-101.50M-65.57M-131.62M-128.24M-107.55M-142.61M-145.50M-159.80M
Investing Activities
Capital ExpendituresCapex
15.70M17.75M0.94M0.86M6.33M3.21M0.40M0.72M0.22M0.08M1.92M0.70M1.29M5.66M4.15M9.35M5.64M5.93M4.33M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-15.70M-17.75M-0.94M-0.86M-6.33M-3.21M-0.40M-0.72M-0.22M-0.08M-1.92M-0.70M-1.29M-5.66M-4.15M-9.35M-5.64M-5.93M-4.33M
Purchase of InvestmentsInvestments Purchased
321.59M31.59M193.13M69.91M467.18M125.18M89.78M201.59M117.73M226.12M142.66M815.24M214.40M121.13M159.11M222.97M335.45M345.65M106.52M727.27M
Sale and Maturity of InvestmentsInvestments Sold
128.57M96.68M129.79M136.04M181.14M157.63M255.68M284.44M190.98M144.78M175.30M165.60M170.05M233.28M275.73M274.00M273.83M280.10M257.94M224.60M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-208.72M47.34M-64.28M65.27M-292.37M29.25M165.50M82.13M73.04M-81.41M32.64M-651.55M-45.05M110.86M105.96M52.88M-70.98M-71.19M145.49M-507.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
47.80M0.27M0.42M0.11M0.21M0.21M0.22M0.22M0.93M2.88M2.89M2.91M2.88M2.70M2.71M2.72M2.74M3.59M
Non-Current Debt
-47.80M-0.27M-0.42M-0.11M-0.21M-0.21M-0.22M-0.22M-0.93M-2.88M-2.89M-2.91M-2.88M-2.70M-2.71M-2.72M-2.74M-3.59M
Net Debt Issuances and RepaymentsNet Debt Issuance
-47.80M-0.27M-0.42M-0.11M-0.21M-0.21M-0.22M-0.22M-0.93M-2.88M-2.89M-2.91M-2.88M-2.70M-2.71M-2.72M-2.74M-3.59M
Change in Capital Stock
Common Stock IssuedStock Issued
27.52M4.08M3.68M6.19M3.60M3.55M5.69M3.12M6.10M123.17M-32.96M6.32M6.48M7.65M6.75M6.94M14.65M11.35M798.15M
Net Shares Issued and RepurchasedNet Shares Issued
27.52M4.08M3.68M6.19M3.60M3.55M5.69M3.12M6.10M123.17M-32.96M6.32M6.48M7.65M6.75M6.94M14.65M11.35M798.15M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
27.52M4.08M3.68M6.19M3.60M3.55M5.69M3.12M6.10M123.17M-32.96M6.32M6.48M7.65M6.75M6.94M14.65M11.35M798.15M
Other financing activitiesOther financing
-4.45M-9.60M-9.60M-10.52M-18.45M-1.18M-0.01M-0.51M-0.72M-3.68M-0.84M-1.49M
Cash from Financing ActivitiesCash from Financing
300.90M19.51M93.85M3.42M389.02M29.89M-7.18M5.48M54.22M168.80M103.79M821.01M3.43M2.38M4.75M78.53M330.47M110.71M7.77M792.86M
Additional items
Exchange Rate EffectFX Effect
-0.02M0.03M0.02M-0.13M0.29M-0.27M-0.68M0.05M0.19M-0.48M-0.60M
Change in Cash
53.41M22.10M2.76M-21.79M12.61M-39.06M36.03M-34.20M31.05M13.33M6.95M70.17M-143.25M47.97M-21.18M2.50M152.03M-102.95M7.32M125.42M
Ending Cash Balance
90.56M112.67M115.42M93.63M106.24M67.18M103.22M69.01M100.07M113.40M120.35M190.52M47.26M95.23M74.06M76.55M228.58M125.63M132.95M258.38M
Free Cash FlowFCF
-54.47M-62.49M-27.75M-91.33M-90.37M-101.40M-122.69M-122.52M-96.43M-74.11M-129.51M-101.23M-102.20M-66.86M-137.28M-132.38M-116.90M-148.25M-151.43M-164.13M
Net Cash FlowNCF
53.41M22.10M2.76M-21.79M12.61M-39.06M36.03M-34.20M31.05M13.35M6.93M70.15M-143.13M47.68M-20.91M3.18M151.94M-103.10M7.76M126.06M
Interest Paid
0.91M3.68M2.71M2.76M0.08M9.61M0.04M9.91M0.03M0.32M10.21M0.67M14.46M0.64M9.65M0.61M9.62M3.04M1.59M10.61M

Cytokinetics Cash Flow Statement API

Pull Cytokinetics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CYTK&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY